Defining the Role of mTOR in Cancer

This publication has 132 references indexed in Scilit:

• A MAP4 kinase related to Ste20 is a nutrient-sensitive regulator of mTOR signalling
  Biochemical Journal, 2007
• The energy sensing LKB1–AMPK pathway regulates p27kip1 phosphorylation mediating the decision to enter autophagy or apoptosis
  Nature Cell Biology, 2007
• FoxOs Are Lineage-Restricted Redundant Tumor Suppressors and Regulate Endothelial Cell Homeostasis
  Cell, 2007
• S6K1 Regulates GSK3 under Conditions of mTOR-Dependent Feedback Inhibition of Akt
  Molecular Cell, 2006
• Current development of mTOR inhibitors as anticancer agents
  Nature Reviews Drug Discovery, 2006
• Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin
  Cancer Cell, 2006
• Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer
  Nature Medicine, 2005
• Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
  Nature Cell Biology, 2004
• mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery
  Cell, 2002
• High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice
  Current Biology, 1998